State-of-the-art plasmid, viral vector, and mRNA
cGMP manufacturing operations.
65,000 sqft. for GMP Plasmid Manufacturing
65,000 sqft. for cGMP Viral Vector Manufacturing
226,000 sqft. for Commercial GMP Viral Vector Manufacturing
Rapid and reliable delivery of CGT products that meet global regulatory requirements
Cell and gene therapy (CGT) developers can encounter numerous challenges in bringing their products to market, so they often enlist a contract development and manufacturing organization (CDMO) to help them through the process. Some CDMOs however, have long lead times for limited production slots, use complex manufacturing platforms that lack scalability, and can generate products that fail to meet quality standards.
CoJourney has a strong track record of success in CGT development and manufacturing. Their optimized platform shortens timelines, lowers costs, and consistently delivers high quality product. Our services support the development, cGMP manufacturing, and analytical testing of plasmids, viral vectors, and mRNA produced in our state-of-the-art manufacturing facilities that meet FDA, EMA, and NMPA guidelines.
Your Partner from Pre-Clinical Development to GMP Manufacturing and Beyond
Flexible, customizable manufacturing capacities and regulatory support that help you bring your cell and gene therapy product to the market faster.
CoJourney is a Contract Manufacturing and Development Organization (CDMO) that serves the product development and manufacturing needs of cell and gene therapy companies globally. The company’s services include process development, cGMP production, analytical method development, and QC testing and release for plasmids, viral vectors and mRNAs. CoJourney has built comprehensive offerings include banking, drug substance production and drug product filling, utilizing proprietary platform processes and extensive expertise.
Robust, scalable platform manufacturing technology for production of mRNA, Vectors, and plasmids at costs
60-70%lower than competitors
Leading Plasmids and AAV manufacturing platform with a proven track record of securing
FDA and CDE INDapprovals
Plasmid manufacturing can scale up to
Viral vector manufacturing can scale up to
mRNA can scale up to
Established partnerships with
Our journey to providing top of the line quality gene therapy CDMO services to biopharmaceutical companies around the world.
News & Events
CoJourney Funding Propels US Expansion
CoJourney secures $30 million financing and announces expansion of US production operations.
Cell and Gene Meeting on Mesa, Carlsbad, CA, USA
Oct 10-12, 2023
ESGCT, Brussels, Belgium
Oct 23-27, 2023
CPhI, Barcelona, Spain
Oct 24-26, 2023
World Vaccine Congress, Santa Clara, CA, USA
Nov 27-30, 2023